Status:
UNKNOWN
Circulating Fetal Cells and Breast Cancer
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Ruban Rose
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-50 years
Brief Summary
After pregnancy, fetal cells remain in a woman's body for years. These cells may be involved in different physiological situations (e.g. wound healing) and diseases (e.g. cancer).The study will evalua...
Detailed Description
Breast cancer is the most common cancer in the female population. The protective mechanism associated with pregnancy is not fully understood. During pregnancy fetal cells cross the placental barrier ...
Eligibility Criteria
Inclusion
- women aged 18-50
- having had a male child
- informed and not having objected to participating in the research.
- Patients:
- \- having a diagnosis of breast cancer
- Controls:
- operated on for benign breast tumors
- cancer free
Exclusion
- autoimmune disease
- immunomodulatory treatment
- history of cancer other than breast cancer
- ongoing hormonal treatment
- women not affiliated to the social security
- under AME (state medical aid)
- under tutorship / curatorship
Key Trial Info
Start Date :
May 14 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04903990
Start Date
May 14 2021
End Date
May 1 2025
Last Update
June 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital de Tenon-Service de Gynécologie Obstétrique et Médecine de la Reproduction
Paris, France, 75020